We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tate & Lyle Plc | LSE:TATE | London | Ordinary Share | GB00BP92CJ43 | ORD 29 1/6P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -30.50 | -5.06% | 572.50 | 1,100,895 | 16:35:13 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 576.00 | 577.00 | 610.00 | 566.50 | 597.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Flavoring Extract,syrup, Nec | 1.65B | 188M | 0.4221 | 13.65 | 2.69B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:35:13 | O | 18 | 575.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/5/2025 | 10:10 | ALNC |  Tate & Lyle flags growth "slightly below" outlook amid tariffs |
| 22/5/2025 | 07:10 | ALNC | *Tate & Lyle expects Ebitda margin improvement |
| 22/5/2025 | 07:00 | UK RNS | Tate & Lyle PLC Final Results |
| 16/5/2025 | 13:30 | ALNC | BROKER NOTES: Citi says risk/reward skewed to upside at Tate & Lyle |
| 14/5/2025 | 09:00 | UK RNS | Tate & Lyle PLC Holding(s) in Company |
| 01/5/2025 | 15:00 | UK RNS | Tate & Lyle PLC Holding(s) in Company |
| 29/4/2025 | 15:30 | UK RNS | Tate & Lyle PLC Holding(s) in Company |
| 28/4/2025 | 17:15 | UK RNS | Tate & Lyle PLC Holding(s) in Company |
| 24/4/2025 | 12:00 | UK RNS | Tate & Lyle PLC Holding(s) in Company |
| 15/4/2025 | 14:29 | ALNC | Tate & Lyle says CP Kelco integration progressing as planned |
Tate & Lyle (TATE) Share Charts1 Year Tate & Lyle Chart |
|
1 Month Tate & Lyle Chart |
Intraday Tate & Lyle Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 22/5/2025 | 19:07 | Tate and Lyle Graph's and Charts | 4,061 |
| 26/11/2021 | 16:20 | TATE Charts | 38 |
| 22/5/2019 | 13:29 | Tate & Lyle FY Preview 23.05.19 | - |
| 03/7/2014 | 09:18 | Darren Sinden bullish on Tate & Lyle PLC live on TipTV | - |
| 10/9/2013 | 05:52 | TATE sweet & sour | 103 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 15:54:17 | 573.00 | 13 | 74.49 | O |
| 15:35:13 | 572.50 | 449,219 | 2,571,778.78 | UT |
| 15:29:58 | 576.00 | 1 | 5.76 | AT |
| 15:29:58 | 576.00 | 84 | 483.84 | AT |
| 15:29:58 | 576.00 | 206 | 1,186.56 | AT |
| Top Posts |
|---|
Posted at 22/5/2025 09:20 by Tate & Lyle Daily Update Tate & Lyle Plc is listed in the Flavoring Extract,syrup, Nec sector of the London Stock Exchange with ticker TATE. The last closing price for Tate & Lyle was 603p.Tate & Lyle currently has 445,429,642 shares in issue. The market capitalisation of Tate & Lyle is £2,565,674,738. Tate & Lyle has a price to earnings ratio (PE ratio) of 13.65. This morning TATE shares opened at 597.50p |
Posted at 22/5/2025 09:47 by whites123 Reading the above I do question the valuation as CP has now added value to the tune of £1.8 Billion.CP Kelco was acquired for $1.8 billion (around £1.4 billion), and its integration into Tate & Lyle strengthens the company’s specialty ingredients portfolio and future earnings potential, then logically, that should raise the overall valuation of Tate & Lyle beyond the original £2.8 billion rumoured bid. In fact, using simple arithmetic, a £2.8–£3 billion valuation might now understate the true worth of the combined business, particularly given market multiples for specialty food ingredient companies are typically higher than for legacy commodities. The original £2.8bn figure reflected Tate & Lyle prior to CP Kelco’s impact. The £3bn rumour is either outdated or conservative, or being deliberately floated to test market reaction. Advent may still be finalising a more competitive valuation that reflects the enhanced business profile post acquisition. I would even argue that any credible takeover would now need to factor in a control premium plus the strategic uplift from CP Kelco, which could easily push the price significantly higher. All I know is that the share price isnt reflecting any of this. |
Posted at 22/5/2025 09:27 by whites123 Rumours Intensify Around Advent’s Takeover of Tate & LyleMarket speculation is mounting around a potential takeover of Tate & Lyle by U.S. private equity giant Advent International. According to credible reports, Advent has been preparing a formal bid since late 2024, when Tate & Lyle’s share price surged above £8.00 on news of their interest. Initial expectations valued the bid at over £2.8 billion. Now, sources suggest the deal is entering its final stages of preparation and internal consideration. The rumoured offer has reportedly grown in scale, with current estimates topping £3 billion — a reflection of both Tate & Lyle’s strategic transformation and strong market positioning in healthier food ingredients. While neither party has officially commented, the market is watching closely. A formal announcement, if made, could mark one of the most significant moves in the UK food sector this year. |
Posted at 22/5/2025 08:49 by wad collector Gotta be patient with TATE I reckon. |
Posted at 22/5/2025 07:45 by whites123 Tate has just wrapped up a big transformation. They’re no longer just a sugar company, they’re now a global player helping food companies make healthier, tastier products.They bought CP Kelco in late 2024, and this is already paying off: Profits (EBITDA) are up 5% across the enlarged group. Cash flow is strong at £190 million, meaning the company generates solid money after expenses. They’re innovating, winning new business, and improving margins. A £216m share buyback and increased dividend show confidence and shareholder focus. Debt is under control and better than expected. Despite a slight dip in revenue due to lower raw material prices (which they passed on to customers), profits and efficiency improved, a sign of good management and a resilient business. 1. Transformation complete – growth ahead: Tate has shifted into a high-margin, health-focused food solutions business. This positions them perfectly for the global demand for healthier food. 2. Acquisition already working: CP Kelco is outperforming expectations, adding scale, innovation, and synergy potential (£50m+ in cost savings targeted). 3. Cash is flowing: With £190m free cash flow and solid earnings, Tate can invest, pay dividends, and reduce debt — all signs of a strong company. 4. Market leadership in “MouthfeelR 5. Upside not priced in: At current levels, the stock doesn’t yet reflect the growth potential from CP Kelco integration and future synergies. In my opinion a return to +£8.00 per share is not just a possibility, it’s a probability. With strong fundamentals, execution, and industry positioning, this price level reflects fair value for the new, transformed Tate & Lyle. |
Posted at 21/5/2025 08:56 by whites123 TATE presents a compelling investment opportunity ahead of its full-year results announcement tomorrow. The company's strategic acquisition and integration of CP Kelco have positioned it for significant growth and value creation.The integration of CP Kelco, operating as one by April 2025, has been executed smoothly, with the combined entity now operating under a unified regional framework encompassing the Americas, Asia Pacific, and EMEA. This consolidation is expected to deliver targeted run-rate cost synergies of US$50 million by the end of the 2027 financial year, with more than 50% anticipated by the end of 2026. In its pre-close statement, Tate & Lyle indicated that the financial results for the year ended March 31, 2025, are expected to be in line with guidance. Notably, CP Kelco is projected to deliver an increase in EBITDA margin of over 90 basis points, surpassing initial expectations and reinforcing confidence in its phased margin recovery. Its focus on healthier food and beverage solutions aligns with global consumer trends. The acquisition of CP Kelco enhances its capabilities in providing natural ingredients like pectin and specialty gums, catering to the growing demand for low-sugar and plant-based products. Given the successful integration of CP Kelco, anticipated cost synergies, and alignment with health-conscious consumer trends, a rebound in Tate & Lyle's share price to £7.00 and above is in my opinion a realistic proposition. The company's strategic initiatives and financial performance position it as a strong buy ahead of the upcoming results announcement. |
Posted at 18/5/2025 10:50 by laurence llewelyn binliner #Pete160, I picked these up in 2022 pre the special payout and consolidation, then bought back the shares I lost and had about 80 pence total return from dividends since, stop losses do have a place, but often stop you out only to watch the share either get a TO or reverse its fortunes through changes in leadership and recover.. :o)A safe, steady dividend here, the payout has been recovering slowly since 2023, and the merge-co will drive profits, TATE will be just fine as they deliver results and economies of scale hit the bottom line.. 22nd this week for the next results and dividend update.. |
Posted at 18/5/2025 09:47 by pete160 I jumped the gun and ramped up my position when it fell to 700 (falling knife and all that) but have held all the way down because of the points above.Another share choice of mine which has become a 'long term investment' which I classify all my clangers as - rather than being more ruthless and using a regimented stop loss. |
Posted at 18/5/2025 09:18 by laurence llewelyn binliner #Pete160, 15.04.2025 - The integration is progressing well and as planned, with Tate & Lyle and CP Kelco operating as one combined business from 1 April 2025..Encouraging to see 500-600 done without a stall inside 2 months.. Synergies are unlikely to be reflected much in the FY results, more the H1, see what we get, looking forward to the results and DPS.. :o) |
Posted at 17/5/2025 14:28 by pete160 If Tate disappoints it will get taken out within the next 12 months.If Tate can show that the integration is going well, the same thing may happen anyway. It's just a matter of price. |
Posted at 17/5/2025 09:31 by laurence llewelyn binliner Looking forward to results next week, see if the CP Kelco integration is adding value yet, but it will most likely be H1 before we see too much reflected in the numbers..15.04.205 - Tate & Lyle performed as expected in Q4 and for the year ended 31 March 2025 will be in line with guidance. Excluding CP Kelco and in constant currency, we expect revenue will be 5% lower and EBITDA will be 4% higher.. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
.png){kind=logo}
